BIOMAT Database Logo BIOMAT Database Logo

[Treatment with the preparation "Visken" (beta blocking agent) in angina pectoris]. 1972

A Mihail, and P Popescu, and X Petrescu, and N Popa

UI MeSH Term Description Entries
D007211 Indoles Benzopyrroles with the nitrogen at the number one carbon adjacent to the benzyl portion, in contrast to ISOINDOLES which have the nitrogen away from the six-membered ring.
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D005069 Evaluation Studies as Topic Works about studies that determine the effectiveness or value of processes, personnel, and equipment, or the material on conducting such studies. Critique,Evaluation Indexes,Evaluation Methodology,Evaluation Report,Evaluation Research,Methodology, Evaluation,Pre-Post Tests,Qualitative Evaluation,Quantitative Evaluation,Theoretical Effectiveness,Use-Effectiveness,Critiques,Effectiveness, Theoretical,Evaluation Methodologies,Evaluation Reports,Evaluation, Qualitative,Evaluation, Quantitative,Evaluations, Qualitative,Evaluations, Quantitative,Indexes, Evaluation,Methodologies, Evaluation,Pre Post Tests,Pre-Post Test,Qualitative Evaluations,Quantitative Evaluations,Report, Evaluation,Reports, Evaluation,Research, Evaluation,Test, Pre-Post,Tests, Pre-Post,Use Effectiveness
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000319 Adrenergic beta-Antagonists Drugs that bind to but do not activate beta-adrenergic receptors thereby blocking the actions of beta-adrenergic agonists. Adrenergic beta-antagonists are used for treatment of hypertension, cardiac arrhythmias, angina pectoris, glaucoma, migraine headaches, and anxiety. Adrenergic beta-Antagonist,Adrenergic beta-Receptor Blockader,Adrenergic beta-Receptor Blockaders,beta-Adrenergic Antagonist,beta-Adrenergic Blocker,beta-Adrenergic Blocking Agent,beta-Adrenergic Blocking Agents,beta-Adrenergic Receptor Blockader,beta-Adrenergic Receptor Blockaders,beta-Adrenoceptor Antagonist,beta-Blockers, Adrenergic,beta-Adrenergic Antagonists,beta-Adrenergic Blockers,beta-Adrenoceptor Antagonists,Adrenergic beta Antagonist,Adrenergic beta Antagonists,Adrenergic beta Receptor Blockader,Adrenergic beta Receptor Blockaders,Adrenergic beta-Blockers,Agent, beta-Adrenergic Blocking,Agents, beta-Adrenergic Blocking,Antagonist, beta-Adrenergic,Antagonist, beta-Adrenoceptor,Antagonists, beta-Adrenergic,Antagonists, beta-Adrenoceptor,Blockader, Adrenergic beta-Receptor,Blockader, beta-Adrenergic Receptor,Blockaders, Adrenergic beta-Receptor,Blockaders, beta-Adrenergic Receptor,Blocker, beta-Adrenergic,Blockers, beta-Adrenergic,Blocking Agent, beta-Adrenergic,Blocking Agents, beta-Adrenergic,Receptor Blockader, beta-Adrenergic,Receptor Blockaders, beta-Adrenergic,beta Adrenergic Antagonist,beta Adrenergic Antagonists,beta Adrenergic Blocker,beta Adrenergic Blockers,beta Adrenergic Blocking Agent,beta Adrenergic Blocking Agents,beta Adrenergic Receptor Blockader,beta Adrenergic Receptor Blockaders,beta Adrenoceptor Antagonist,beta Adrenoceptor Antagonists,beta Blockers, Adrenergic,beta-Antagonist, Adrenergic,beta-Antagonists, Adrenergic,beta-Receptor Blockader, Adrenergic,beta-Receptor Blockaders, Adrenergic
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

A Mihail, and P Popescu, and X Petrescu, and N Popa
[Treatment of angina pectoris with an adrenergic beta receptor blocking agent].
January 1966, Medizinische Klinik,
A Mihail, and P Popescu, and X Petrescu, and N Popa
[Treatment of angina pectoris with beta-blocking agents].
January 1974, Semaine des hopitaux. Therapeutique,
A Mihail, and P Popescu, and X Petrescu, and N Popa
A new beta adrenergic blocking agent, propranolol, in the treatment of angina pectoris.
February 1968, Canadian Medical Association journal,
A Mihail, and P Popescu, and X Petrescu, and N Popa
[Clinical trials with the beta adrenergic blocking agent Visken].
June 1972, Orvosi hetilap,
A Mihail, and P Popescu, and X Petrescu, and N Popa
Treatment of hypertension with a new beta-blocking agent, pindolol (Visken).
December 1973, European journal of clinical pharmacology,
A Mihail, and P Popescu, and X Petrescu, and N Popa
[USE OF A BETA ADRENERGIC BLOCKING AGENT IN ANGINA PECTORIS].
February 1965, La Clinica terapeutica,
A Mihail, and P Popescu, and X Petrescu, and N Popa
[Propranolol (a new beta adrenergic blocking agent) in angina pectoris].
January 1967, Archivos del Instituto de Cardiologia de Mexico,
A Mihail, and P Popescu, and X Petrescu, and N Popa
[Eraldin: a cardioselective beta-adrenergic receptor blocking agent in the treatment of angina pectoris].
August 1971, Polski tygodnik lekarski (Warsaw, Poland : 1960),
A Mihail, and P Popescu, and X Petrescu, and N Popa
The treatment of angina pectoris with a new beta-receptor blocking agent (H 56/28).
September 1967, Acta medica Scandinavica,
A Mihail, and P Popescu, and X Petrescu, and N Popa
[Treatment of angina pectoris with a ganglion-blocking agent ganglerone].
April 1957, Terapevticheskii arkhiv,
Copied contents to your clipboard!